Sinopep-Allsino Biopharmaceutical Co., Ltd. is a prominent innovation-driven company based in China, specialising in the development and manufacturing of peptides, oligonucleotides, and small molecules. With extensive experience and expertise, Sinopep provides products for research, clinical development, and commercial applications to pharmaceutical and biotechnology companies worldwide. The company offers comprehensive Contract Development and Manufacturing Organisation (CDMO) and Contract Research Organisation (CRO) services. It operates three research and development centres along with two manufacturing sites, both of which are approved by EDQM and FDA. Most of the drug substances developed by Sinopep have received approval in markets such as the US, EU, UK, and China.

Services include:
- Active Pharmaceutical Ingredients (APIs)
- Peptide development and manufacturing
- Oligonucleotide production
- Small molecule research and development
- CDMO services
- CRO services
- Preclinical to commercial support

Sinopep-Allsino Biopharmaceutical Co., Ltd. continues to lead the pharmaceutical industry by providing high-quality services and products tailored to the needs of its clients. For more information, please visit sinopep.com.